Boundless Bio
Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with oncogene amplified cancers.
Last updated on
About Boundless Bio
Founded
2018Employees
51-250Funding / Mkt. Cap
$251MCategory
Industry
BiotechnologyLocation
City
La JollaState
CaliforniaCountry
United StatesBoundless Bio
Find your buyer within Boundless Bio